Curadh

Curadh MTR debuts at BioEquity, Europe with New CEO and expanded leadership team

14 May 2024 – Pennsylvania, US and Edinburgh, UK – Curadh MTR Inc, leading the development of second generation radiopharmaceuticals, designed to eradicate solid tumours, today announced its emergence from stealth with the appointment of Glenn Kazo as chief executive officer and Amrik Basran as chief scientific officer.  At BioEquity Europe in San Sebastian, Spain...
2548 Veronica Drive, Chester Springs, PA 19425, US